|Bid||26.57 x 800|
|Ask||27.50 x 1800|
|Day's Range||25.96 - 26.81|
|52 Week Range||21.24 - 33.00|
|Beta (5Y Monthly)||0.60|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 27, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.78|
Subscribe to Yahoo Finance Plus to view Fair Value for ALKS
Here is how Alkermes (ALKS) and Elevance Health (ELV) have performed compared to their sector so far this year.
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
Alkermes (ALKS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.